Clinical trial
Intrathecal Mafosfamide
NCT00062881 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00062881 |
|---|---|
| Title | Intrathecal Mafosfamide |
| Official title | Phase I Study of Intrathecal Mafosfamide |
| Lead sponsor | Baylor College of Medicine, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Malignant Meningeal Neoplasms |
| Intervention type | Drug |
| Interventions | Intrathecal Mafosfamide |
| Enrollment | 65 |
| Start date | Jun 1, 1990 |
| Completion | Sep 1, 2005 |
| First posted | Jun 18, 2003 |
| Last update posted | Mar 4, 2020 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: